Avg closing price
Price range

12 Joel Greenblatt Catalyst Pharmaceuticals Trades

Joel Greenblatt acquired 37.5 Thousand Catalyst Pharmaceuticals shares worth $610 Thousand. That's 0.01% of their equity portfolio (926th largest holding). The first Catalyst Pharmaceuticals trade was made in Q3 2019. Since then Joel Greenblatt bought shares four more times and sold shares on seven occasions. The stake costed the investor $566 Thousand, netting the investor a gain of 7.8% so far.

Avg closing price
Price range
Sold 67.1% shares (-76.5 Thousand shares) Q4 2023
Avg closing price $13.67
Price range $11.78 - $17.29
Increased shares by 3.2% (+3.53 Thousand shares) Q3 2023
Avg closing price $13.38
Price range $11.69 - $15.02
Sold 20.8% shares (-29 Thousand shares) Q2 2023
Avg closing price $14.39
Price range $11.50 - $18.08
Increased shares by 632.2% (+120 Thousand shares) Q1 2023
Avg closing price $16.50
Price range $14.34 - $21.05
Sold 62.0% shares (-31.1 Thousand shares) Q4 2022
Avg closing price $15.40
Price range $12.25 - $19.50
New holding (+50.2 Thousand shares) Q3 2022
Avg closing price $11.85
Price range $7.06 - $15.52
Sold -32.7 Thousand shares Q4 2020
Avg closing price $3.36
Price range $2.97 - $3.83
Sold 53.3% shares (-37.2 Thousand shares) Q3 2020
Avg closing price $3.91
Price range $2.97 - $5.08
Sold 45.0% shares (-57.1 Thousand shares) Q2 2020
Avg closing price $4.49
Price range $3.48 - $5.05
Increased shares by 247.6% (+90.4 Thousand shares) Q1 2020
Avg closing price $4.10
Price range $2.61 - $5.21
Sold 8.3% shares (-3.31 Thousand shares) Q4 2019
Avg closing price $4.68
Price range $3.67 - $5.70
New holding (+39.8 Thousand shares) Q3 2019
Avg closing price $5.33
Price range $3.89 - $7.43

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!